Pharma Partnership HTI Plastics specializes in pharmaceutical injection molding and exhibits active participation in industry events like DCAT Week and CPHI (North America and Global). This suggests strong alignment with pharmaceutical manufacturers and potential for expanded medical device and drug delivery component opportunities.

Medical Device Focus With FDA registration and ISO 9001:2015 certification and a track record in medical device components, HTI is well-positioned to target medical OEMs seeking reliable, regulatory-compliant injection molded parts, including proprietary solutions.

Strategic Partnerships HTI is a division of PCE, Inc., which has broader capabilities in blow-molding and extrusion. This enables cross-sell of complementary manufacturing processes to existing customers and can open doors to integrated packaging or multi-process programs.

Industry Exposure Active participation in SHOT Show Supplier Showcase and Design-2-Part events indicates access to the shooting sports, outdoor, and engineering communities. These channels can be leveraged to source new OEMs for ruggedized medical or consumer packaging components.

Growth Signals Revenue range ($25M-$50M) and leadership promotions (Senior Engineer - Sales) signal organizational focus on growth, client relationship expansion, and technical sales capability—addressable markets include pharmaceutical, medical devices, and specialty packaging.